Nomogram of conditional survival probability of long-term Survival for Metastatic Colorectal Cancer: A Real-World Data Retrospective Cohort Study from SEER database
- PMID: 34233209
- DOI: 10.1016/j.ijsu.2021.106013
Nomogram of conditional survival probability of long-term Survival for Metastatic Colorectal Cancer: A Real-World Data Retrospective Cohort Study from SEER database
Abstract
Background: Many patients with metastatic colorectal cancer (mCRC) have better prognosis than the prediction at diagnosis. Compared with invariable traditional Kaplan Meier assessment, conditional survival (CS) assessment has become a more accurate and informative assessment method to predict survival time.
Materials and methods: Patients with mCRC between 2010 and 2015 were extracted from Surveillance, Epidemiology and End Results linked database. CS analysis was applied to depict exact survival for patients who have survived for specific year and standardized difference (d) was used to evaluate the differences between subgroups in CS analysis. Based on variables selected by Lasso analysis, nomograms for each year after diagnosis were fitted to estimate 3-year survival of stage IV CRC, respectively.
Results: Of 9732 patients, overall actuarial survival (OS) decreased from 24% at 4-year to 16% at 6-year, while corresponding 3-year CS (CS3) increased from 33% at 1-year to 48% at 3-year. Overall, CS3 was higher than corresponding actuarial survival. All clinicopathological characteristics were associated with actuarial survival (p < 0.05). However, in CS3 analysis, survival difference caused by gender, race and tumor size gradually disappeared over time (|d|>0.1→ |d|<0.1). Furthermore, survival difference caused by histological type, brain metastasis and chemotherapy reversed over time (d > 0→d<0 or d<0→d>0). Based on lasso analysis, nomograms for 1st, 2nd and 3rd year after diagnosis were conducted respectively. The AUC of nomogram for 1st year was 0.705, for 2nd year was 0.675, and for 3rd year was 0.648.
Conclusion: Patients with mCRC demonstrated a substantial increase in CS over time. Risk factors collected at diagnosis may change gradually. Nomograms constructed by survival time can predict more accurate survival for patients with mCRC. Conditional survival assessments provide important quantitative information about the probability of survival and are therefore of great value to patients and health care professionals.
Keywords: Conditional survival; Nomogram; Prognosis; SEER.
Copyright © 2021. Published by Elsevier Ltd.
Comment in
-
A commentary on "nomogram of conditional survival probability of long-term Survival for Metastatic Colorectal Cancer: A Real-World Data Retrospective Cohort Study from SEER database" (Int J Surg 2021; 106013).Int J Surg. 2021 Aug;92:106039. doi: 10.1016/j.ijsu.2021.106039. Epub 2021 Jul 30. Int J Surg. 2021. PMID: 34339881 No abstract available.
-
A commentary on "Nomogram of conditional survival probability of long-term Survival for Metastatic Colorectal Cancer: A Real-World Data Retrospective Cohort Study from SEER database" [Int. J. Surg. 92 (2021) 106013].Int J Surg. 2021 Nov;95:106147. doi: 10.1016/j.ijsu.2021.106147. Epub 2021 Oct 28. Int J Surg. 2021. PMID: 34737142 No abstract available.
-
A commentary on "Nomogram of conditional survival probability of long-term survival for metastatic colorectal cancer: A real-world data retrospective cohort study from SEER database" [Int. J. Surg. 92 (2021) 106013].Int J Surg. 2022 May;101:106623. doi: 10.1016/j.ijsu.2022.106623. Epub 2022 Apr 14. Int J Surg. 2022. PMID: 35430339 No abstract available.
-
A commentary on "Nomogram of conditional survival probability of long-term survival for metastatic colorectal cancer: A real-world data retrospective cohort study from seer database" (Int J Surg 2021;92:106013).Int J Surg. 2022 Jun;102:106681. doi: 10.1016/j.ijsu.2022.106681. Epub 2022 May 26. Int J Surg. 2022. PMID: 35642829 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources